Literature DB >> 17292394

Mechanistic basis for the pathogenesis of long QT syndrome associated with a common splicing mutation in KCNQ1 gene.

Keiko Tsuji1, Masaharu Akao, Takahiro M Ishii, Seiko Ohno, Takeru Makiyama, Kotoe Takenaka, Takahiro Doi, Yoshisumi Haruna, Hidetada Yoshida, Toshihiro Nakashima, Toru Kita, Minoru Horie.   

Abstract

Mutations in KCNQ1, the gene encoding the delayed rectifier K(+) channel in cardiac muscle, cause long QT syndrome (LQTS). We studied 3 families with LQTS, in whom a guanine to adenine change in the last base of exon 7 (c.1032G>A), previously reported as a common splice-site mutation, was identified. We performed quantitative measurements of exon-skipping KCNQ1 mRNAs caused by this mutation using real-time reverse transcription polymerase chain reaction. Compared with normal individuals who have minor fractions of splicing variants (Delta7-8: 0.1%, Delta8: 6.9%, of total KCNQ1 transcripts), the affected individuals showed remarkable increases of exon-skipping mRNAs (Delta7: 23.5%, Delta7-8: 16.8%, Delta8: 4.5%). Current recordings from Xenopus laevis oocytes heterologously expressing channels of wild-type (WT) or exon-skipping KCNQ1 (Delta7, Delta7-8, or Delta8) revealed that none of the mutants produced any measurable currents, and moreover they displayed mutant-specific degree of dominant-negative effects on WT currents, when co-expressed with WT. Confocal microscopy analysis showed that fluorescent protein-tagged WT was predominantly expressed on the plasma membrane, whereas the mutants showed intracellular distribution. When WT was co-expressed with mutants, the majority of WT co-localized with the mutants in the intracellular space. Finally, we provide evidence showing direct protein-protein interactions between WT and the mutants, by using fluorescence resonance energy transfer. Thus, the mutants may exert their dominant-negative effects by trapping WT intracellularly and thereby interfering its translocation to the plasma membrane. In conclusion, our data provide a mechanistic basis for the pathogenesis of LQTS caused by a splicing mutation in KCNQ1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292394     DOI: 10.1016/j.yjmcc.2006.12.015

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

Review 1.  Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling.

Authors:  Kai-Chien Yang; Jeanne M Nerbonne
Journal:  Trends Cardiovasc Med       Date:  2015-07-17       Impact factor: 6.677

2.  Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy.

Authors:  Tara Klassen; Caleb Davis; Alica Goldman; Dan Burgess; Tim Chen; David Wheeler; John McPherson; Traci Bourquin; Lora Lewis; Donna Villasana; Margaret Morgan; Donna Muzny; Richard Gibbs; Jeffrey Noebels
Journal:  Cell       Date:  2011-06-24       Impact factor: 41.582

Review 3.  Molecular Pathophysiology of Congenital Long QT Syndrome.

Authors:  M S Bohnen; G Peng; S H Robey; C Terrenoire; V Iyer; K J Sampson; R S Kass
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  Post-mortem Whole exome sequencing with gene-specific analysis for autopsy-negative sudden unexplained death in the young: a case series.

Authors:  Nupoor Narula; David J Tester; Anna Paulmichl; Joseph J Maleszewski; Michael J Ackerman
Journal:  Pediatr Cardiol       Date:  2014-12-13       Impact factor: 1.655

5.  Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Authors:  Arthur J Moss; Wataru Shimizu; Arthur A M Wilde; Jeffrey A Towbin; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Michael J Ackerman; Elizabeth S Kaufman; Nynke Hofman; Rahul Seth; Shiro Kamakura; Yoshihiro Miyamoto; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

6.  A splice site mutation in hERG leads to cryptic splicing in human long QT syndrome.

Authors:  Qiuming Gong; Li Zhang; Arthur J Moss; G Michael Vincent; Michael J Ackerman; Jeffrey C Robinson; Melanie A Jones; David J Tester; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2008-01-17       Impact factor: 5.000

7.  Conformational changes of an ion-channel during gating and emerging electrophysiologic properties: Application of a computational approach to cardiac Kv7.1.

Authors:  Ali Nekouzadeh; Yoram Rudy
Journal:  Prog Biophys Mol Biol       Date:  2015-12-30       Impact factor: 3.667

8.  Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.

Authors:  Peter J Schwartz; Cristina Moreno; Maria-Christina Kotta; Matteo Pedrazzini; Lia Crotti; Federica Dagradi; Silvia Castelletti; Kristina H Haugaa; Isabelle Denjoy; Maria A Shkolnikova; Paul A Brink; Marshall J Heradien; Sandrine R M Seyen; Roel L H M G Spätjens; Carla Spazzolini; Paul G A Volders
Journal:  Eur Heart J       Date:  2021-12-07       Impact factor: 29.983

9.  Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Dongrui Ma; Heming Wei; Jun Lu; Dou Huang; Zhenfeng Liu; Li Jun Loh; Omedul Islam; Reginald Liew; Winston Shim; Stuart A Cook
Journal:  Stem Cell Res Ther       Date:  2015-03-19       Impact factor: 6.832

10.  KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1.

Authors:  Jamie D Kapplinger; Anders Erickson; Sirisha Asuri; David J Tester; Sarah McIntosh; Charles R Kerr; Julie Morrison; Anthony Tang; Shubhayan Sanatani; Laura Arbour; Michael J Ackerman
Journal:  J Med Genet       Date:  2017-03-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.